Aldeyra Therapeutics
ALDX
$4.07
Share price
3.58%
Change (1 day)
-57.29%
Change (1 year)
Categories
Aldeyra Therapeutics (ALDX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $28.53 M
According to Aldeyra Therapeutics 's latest financial reports the company's total liabilities are $28.53 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Aldeyra Therapeutics - Total liabilities on balance sheet (from 2012 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $28.53 M | -5.78% |
| 2022-12-31 | $30.28 M | 10.52% |
| 2021-12-31 | $27.4 M | 14.92% |
| 2020-12-31 | $23.84 M | -13.09% |
| 2019-12-31 | $27.43 M | 223.8% |
| 2018-12-31 | $8.47 M | 85.25% |
| 2017-12-31 | $4.57 M | 29.29% |
| 2016-12-31 | $3.53 M | 6.36% |
| 2015-12-31 | $3.32 M | 32.9% |
| 2014-12-31 | $2.5 M | -55.68% |
| 2013-12-31 | $5.64 M | -79.19% |
| 2012-12-31 | $27.13 M | 946.16% |
| 2011-12-31 | $2.59 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $7.10 B | 24,809.31% | 🇺🇸 USA |